Image: Dr Chris Bakal presenting to industry at Harwell. Image credit: The Institute of Cancer Research.
Researchers from Harwell – home to more than 225 organisations and well-known as a base for the UK Space Agency – and other companies spoke to ICR scientists and staff from our Enterprise Unit after a series of presentations about the ICR’s research and our work with commercial partners.
The event was the latest in our Partnering to Defeat Cancer series, which has already seen our Enterprise Unit and researchers visit the Royal Society in London and the Babraham Institute in Cambridge.
At the famous Rutherford Appleton Laboratory in Harwell, delegates heard about a range of our cutting-edge research, our culture of collaboration with industry, recent examples of our success and upcoming opportunities for possible partnership.
After introductions to our sector-leading work with industry from the ICR’s Director of Enterprise Dr Angela Kukula and Associate Director of Business Development Dr Toby Richardson, Dr Maggie Cheang, Team Leader in Genomic Analysis (Clinical Trials) and Dr Chris Bakal, Team Leader in Dynamical Cell Systems, gave presentations on their work.
Possibilities for collaboration
Nigel Brooks, Director at CellCentric Ltd, introduced his work with the ICR to develop a late-stage prostate drug and Dr Barbara Camanzi, Healthcare Lead at the Science and Technology Facilities Council (STFC), gave an overview of opportunities for innovative partnerships with researchers at Harwell.
Andy Carr, Business Development Manager in the ICR's Enterprise Unit, said: “It was a pleasure to host our third Partnering to Defeat Cancer event in Harwell and complete the ‘golden triangle’ in Oxford, having already put on networking events for industry and our scientists in London and Cambridge.
“So far, our events have led to dozens of new interactions with possible new commercial partners. Industry staff are very interested in a range of upcoming future possibilities for collaboration, including at The London Cancer Hub.”
For more information about future events in the Partnering to Defeat Cancer series please contact Andy Carr or sign up to our Enterprise newsletter, Connections.